Welcome to our dedicated page for SiriusPoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SiriusPoint Ltd. SEC filings document the regulatory record of a global specialty insurance and reinsurance underwriter. Its 8-K filings report operating results, financial supplements, investor presentations, business-structure changes, executive transitions, and other material events. Regulation FD exhibits provide additional detail on underwriting performance, services income, investment results, capital management, and risk-based capital measures.
The company’s proxy materials describe board elections, director independence, committee assignments, executive compensation, shareholder voting matters, and governance practices. Filings also disclose SiriusPoint’s capital structure, including common stock and preference-share matters, and include records such as Form 25 for the removal from listing and registration of its 8.00% Resettable Fixed Rate Preference Shares, Series B.
SiriusPoint Ltd insider Scott Egan, the company’s Chief Executive Officer and a director, reported a transaction involving company common shares. On 12/12/2025, 21,801 common shares were recorded in a transaction coded F.
The filing explains that these shares were withheld to cover current tax liabilities in connection with the vesting of restricted share units. Following this transaction, Egan directly beneficially owns 784,166 SiriusPoint common shares, which the filing notes include restricted shares.
A shareholder of the SPNT issuer has filed a Rule 144 notice to sell 37,311 shares of common stock. The sale is planned to occur around 12/12/2025 on the NYSE through J.P. Morgan Securities LLC. Based on the filing, the aggregate market value of the shares to be sold is $831,289.08, compared with 116,814,640 shares of the same class outstanding. The shares were originally acquired on 12/31/2012 as a gift from Clare Loeb, who had acquired the shares earlier. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.
SiriusPoint Ltd. reported an insider equity transaction by its Group Chief Underwriting Officer, Anthony Shapella. On 11/30/2025, 2,375 common shares were withheld with a transaction code "F," which indicates shares were surrendered to cover current tax liabilities related to the vesting of restricted shares. The price is shown as $0 because this is a tax withholding event rather than an open-market sale or purchase.
After this transaction, Shapella beneficially owned 42,215 common shares, which the disclosure notes include restricted shares. This type of activity is administrative in nature and reflects routine handling of taxes when equity awards vest.
Donald Smith & Co., Inc. filed a Schedule 13G reporting a passive stake in SiriusPoint Ltd (SPNT). The filer reports 7,402,682 shares beneficially owned, representing 6.34% of the common stock as of the event date 09/30/2025.
The filing lists sole voting power over 7,135,119 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P., and sole dispositive power over 7,339,609 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,700,000 shares of SiriusPoint Ltd. (SPNT), representing 5.7% of the class as of the event date September 30, 2025.
The filer reports sole voting power: 6,700,000 and sole dispositive power: 6,700,000, with no shared voting or dispositive power. The percentage is based on 116,759,539 shares believed outstanding. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Wellington Management Group LLP, together with affiliated entities, filed an amended Schedule 13G reporting beneficial ownership in SiriusPoint Ltd. (SPNT).
They reported 4,297,864 shares beneficially owned, representing 3.68% of the common stock, as of the event date 09/30/2025. Wellington reported 0 shares with sole voting or dispositive power, 3,321,795 shares with shared voting power, and 4,297,864 shares with shared dispositive power.
The shares are owned of record by clients of Wellington’s investment adviser affiliates. Wellington stated that no single client is known to have rights to more than five percent of the class and certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.
The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.
SiriusPoint Ltd. (SPNT) reported a stronger quarter. Q3 revenue reached $755.9 million, up from $562.2 million a year ago, driven by higher net premiums earned of $647.7 million. Net income rose to $90.7 million versus $8.7 million, with diluted EPS of $0.73. Underwriting stayed profitable with a combined ratio of 89.1% and underwriting income of $91.4 million. Net investment income was $66.5 million.
The company agreed to sell ArmadaCorp Capital for $250 million, classifying it as held-for-sale and guiding to a pre-tax gain of $220–$230 million, subject to customary closing conditions and regulatory approvals in the fourth quarter of 2025. Operating cash flow improved to $128.8 million for the nine months, while financing cash outflows included $490.8 million of common share repurchases. Shareholders’ equity attributable to SiriusPoint rose to $2,209.9 million, helped by a swing in accumulated other comprehensive income to $52.3 million. Common shares outstanding were 116,814,640 as of October 29, 2025.
SiriusPoint Ltd. (SPNT) filed an 8-K stating it furnished its third-quarter 2025 results press release (Exhibit 99.1), a financial supplement (Exhibit 99.2), and an investor slide presentation (Exhibit 99.3). These materials were provided under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act.
Under Item 8.01, the Audit Committee approved a quarterly cash dividend of $0.50 per share on the company’s 8.00% Resettable Fixed Rate Preference Shares, Series B, payable on November 28, 2025 to shareholders of record on November 13, 2025 (press release in Exhibit 99.4).